Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

R&D Systems | Catalog # SPCKB-PS-011938

Simple Plex Human Phospho-Tau (T217) ALZpath assay kit for use on the Ella instrument. Contains Cartridge, Sample Diluent SD06, and Wash Buffer. Sample type indicated with PS (Plasma/Serum).
R&D Systems
Loading...

Key Product Details

Assay Length

90 minutes

Sample Type & Volume Required Per Well*

Serum (25 µL), EDTA Plasma (25 µL), Heparin Plasma (25 µL), Cerebrospinal Fluid (25 µL)

Sensitivity

0.09 pg/mL

Assay Range

0.32-1200 pg/mL (Serum, EDTA Plasma, Heparin Plasma, Cerebrospinal Fluid)

Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge Summary

Simple Plex assay is for the detection of human Phospho-Tau 217 in serum, plasma (EDTA/Heparin), and cerebrospinal fluid (CSF) in Sample Diluent SD06.

*The Sample Volume represented is based on the amount of sample incorporated into the reaction after taking into account the assay's minimum required dilution for a given matrix. Serial dilution may be necessary to achieve some of the final sample volumes represented.

Compatible Instruments

Ella Automated Immunoassay System

Ella Automated Immunoassay System

Efficiently analyze biomarkers with Ella's advanced technology, providing accurate, precise results in under 90 minutes. Quantify up to 8 targets per assay through a streamlined automated workflow. Choose from >350 highly validated Simple Plex assays or Simple Plex discovery assays.
Loading...

Product Specifications

Assay Type

Automated sandwich ELISA

Format

Microfluidic cartridge containing three Glass Nano Reactors (GNR)

Species

Human

Specificity

Natural and recombinant human phospho-Tau. 

Cross-reactivity

< 0.5% cross-reactivity observed with available related molecules. < 50% cross-species reactivity observed with species tested.

Interference

No significant interference observed with available related molecules.

Precision

Intra-Assay Precision (Precision within an assay) Each control was tested multiple times in one Phospho-Tau 217 assay.

Inter-Assay Precision (Precision between assays) Replicates of each Phospho-Tau 217 control were tested in multiple assays performed by at least three technicians using two lots of reagents for human Phospho-Tau 217.

Cerebrospinal Fluid, EDTA Plasma, Heparin Plasma, Serum

Intra-Assay Precision Inter-Assay Precision
Sample 1 2 1 2
n 16 16 66 66
Mean (pg/mL) 8.3 444 8.7 422
Standard Deviation 0.36 19.9 0.91 38.0
CV% 4.3 4.5 10.5 8.9

Recovery for Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

Recovery for the Human Phospho-Tau 217 ALZpath assays was evaluated at three different spiked concentrations of p-Tau 217 protein.

Sample Type Average % Recovery Range %
Cerebrospinal Fluid (n=4) 138 131-142
EDTA Plasma (n=4) 97 83-109
Heparin Plasma (n=4) 92 82-98
Serum (n=4) 92 87-96

Linearity

Samples containing and/or spiked with high concentrations of recombinant human phospho-tau 217 were serially diluted with Sample Diluent to produce samples within the dynamic range of the assay.

Simple Plex Human Phospho-Tau 217 Assay Linearity

Scientific Data Images for Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

Simple Plex Human Phospho-Tau 217 Assay Standard Curve

Simple Plex Human Phospho-Tau 217 Assay Standard Curve

Data shown represents typical performance results for Lower Limit of Quantitation (LLOQ) and Upper Limit of Quantitation (ULOQ) for Human Phospho-Tau 217 ALZpath Assay. Assay range is 0.32 to 1,200 pg/mL.
Simple Plex P-Tau 217 ALZpath Assay Functional LLOQ and LOD

Human Phospho-Tau 217 ALZpath Assay Endogenous Sample Values

EDTA plasma and CSF samples from apparently healthy individuals were tested with the Simple Plex Human Phospho-Tau 217 ALZpath Assay. With this small cohort of samples, 100% detectability of CSF samples was observed and 22% of EDTA plasma samples were detectable above the assays functional limit of detection (LOD) of 0.09 pg/mL. Functional LOD and functional LLOQ are calculated as the LOD and LLOQ of the assay multiplied by the minimum required dilution (MRD) for the sample type.
Phosphorylated Tau 217 Levels In Alzheimer’s Disease Samples

Plasma and CSF p-Tau 217 Levels in Alzheimer’s Disease Patients

Plasma and CSF p-tau 217 levels of healthy control donors and clinically diagnosed Alzheimer’s disease patients were measured using the Simple Plex Human Phospho-Tau 217 ALZpath Assay. ATN positive patients (ATN+) showed elevated plasma and CSF phosphorylated tau 217 levels when compared to both healthy controls as well as ATN negative patients (ATN-). Significant difference in CSF phosphorylated tau 217 levels was also found upon comparison of ATN+ and Amyloid positive (A+) patient groups.

Preparation and Storage

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: Tau

The Tau protein is a microtubule-associated protein expressed primarily in axons of central nervous system neurons. Tau is also detected in oligodendrocytes, the somatodendritic compartment within neurons, and some non-neuronal tissues. In healthy neurons, Tau promotes the assembly and stabilization of microtubules along with other MAP proteins, especially MAP1B. It is believed that other proteins can compensate for loss of Tau protein function as Tau knockout mice are viable and show no signs of neurodegeneration. There are multiple isoforms of Tau created by alternative splicing of exons 2, 3, and 10. And Tau protein is heavily phosphorylated throughout the protein mostly occurring on Ser-Pro and Thr-Pro motifs. Several kinases and phosphatases regulate the phosphorylation state of Tau.

Hyperphosphorylation of Tau is an underlying cause of tauopathies, a group of neurodegenerative diseases that are characterized by accumulation of misfolded Tau protein into neurofibrillary tangles (NFT). Alzheimer’s disease and Parkinson’s disease are two tauopathies. Hyperphosphorylated Tau protein exhibits lower affinity for microtubules resulting in destabilization of the cytoskeleton and a reduction in axonal transport. When Tau protein gets hyperphosphorylated, it promotes misfolding and oligomerization into NFT ultimately causing neuronal impairment and cell death.

Long Name

Microtubule-Associated Protein Tau

Alternate Names

MAPT, MSTD, MTBT1, Neurofibrillary tangle protein, PPND

Entrez Gene IDs

4137 (Human); 17762 (Mouse); 29477 (Rat)

Gene Symbol

MAPT

Additional Tau Products

Product Documents for Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

Loading product document information...

Loading product document information...

Certificate of Analysis

To download a Certificate of Analysis, please enter your Simple Plex catalog number and lot number in the search boxes below.

Product Specific Notices for Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

For research use only

Citations for Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

View all citations for the Simple Plex platform.

Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

Customer Reviews for Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge

There are currently no reviews for this product. Be the first to review Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge and earn rewards!

Have you used Simple Plex Human Phospho-Tau (T217) ALZpath Cartridge?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card
Loading...